INERIS, MIV/TEAM
Parc ALATA, BP 2
5, rue Taffanel
60550 Verneuil en Halatte, France
Health risk assessment (HRA) of substances is essential for the protection of the human population. It consists of identify the hazard, characterise it, determine the exposure and characterise the risk. However, the relationship between external exposure and internal dose is not easy to demonstrate with the classical HRA studies. The use of mechanistic models such as pharmacokinetic or toxicokinetic models is an alternative way of linking external exposure and dose in organ or tissue. These models can be coupled with pharmacodynamic or toxicodynamic models to link external exposure, internal dose and adverse effects on an organ or tissue.
Physiologically based toxicokinetic modelling (PBTK) is a mechanistic approach used to describe and quantify absorption, distribution, metabolism and elimination (ADME) processes that are based on physiological, anatomical, biochemical mechanisms and the physicochemical properties of the molecule. Their use in toxicology allows the results of exposure studies in animals to be extrapolated to predict the internal dose in humans. An Adverse Outcome Pathway (AOP) is a conceptualized framework that describes a sequence of events leading to an adverse effect. AOPs are one of these new tools that make it possible to link the internal dose received by a target organ or tissue to an adverse effect. There are different types of AOPs: qualitative AOPs, which are purely descriptive, and semi-quantitative or quantitative AOPs (qAOPs), which make it possible to estimate the exposure dose corresponding to the appearance of the adverse effect.
The aim of thesis project is to develop a predictive tool for predicting the effects of chemical substances in humans, by coupling a PBTK model to predict the internal exposure of individuals and AOP to predict the effects related to this exposure. Lead was chosen as the study substance. It is a ubiquitous molecule and its effects on the general population are known and well documented. Lead affects the development of the nervous system in children and several epidemiological studies have shown a positive correlation between the lead concentrations in blood and a decline of the intelligence quotient (IQ). We will develop a PBTK model to describe the disposition of lead in the prenatal period and in early childhood coupled with a qAOP to predict effects on brain development.
October 2020
(in progress)
PhD candidate in toxicology modeling, Predicting the adverse effects of lead during pregnancy.
Thesis directors, Dr Rémy Beaudouin and Co-director, Dr Céline Brochot
INERIS MIV/TEAM
Verneuil-en-Halatte, Fr
February 2019 August 2019
Quantitative system pharmacology modeling, Set up of a quantitative system pharmacology model applied in fibrosis disease.
PK/PD Non-clinical team – UCB Pharma.
Slough, UK
October 2017 September 2018
Research assistant in pharmacology, Prediction of human plasma concentration-time profiles from preclinical data using ADME WorkBenchTM software and retrospective analysis.
Department of Drug Metabolism and Pharmacokinetics – Sanofi R&D
Alfortville, Fr
May 2017
July 2017
Laboratory technician, Characterization of antiviral and immunomodulatory effects of antimicrobial peptides (AMPs) using human keratinocytes infected by Herpes Simplex Virus type 1 (HSV-1).
Laboratory of Inflammation, Epithelial tissues and Cytokines, University Hospital Center of Poitiers
Poitiers, Fr
May 2015
June 2015
Role of CB1 receptor in the drug vulnerability or addiction and environmental influence on the emotional state and involvement of the endocannabinoid system.
Laboratory of Experimental and Clinical Neurosciences, Inserm U1084
Poitiers, Fr
October 2020
(in progress)
PhD candidate in toxicokinetic modelling
INERIS, ABIES doctoral school, AgroPariTech (Verneuil-en-Halatte, Fr)
2018-2019
Master’s degree, specialization in Pharmaceutical sciences (Option: From the Active Principle to Drug).
University of Paris Descartes (Paris, Fr)
2016-2018
Master’s degree, specialization in Biology-Health and Pharmaceutical sciences (Option: Cell Engineering).
University of Poitiers (Poitiers, Fr)
2012-2016
Bachelor’s degree, specialization in Life Sciences (Option: Biochemistry, Molecular, Cellular Biology and Genetic).
University of Poitiers (Poitiers, Fr)
French: Mother tongue
English: Lower intermediate level
Software: Microsoft Office, R-studio, Phoenix WinNonlinTM, GNU MCSim